Get the Stockscreener App
4.63
7.03%
-0.35
Profound Medical Corp stock is traded at $4.63, with a volume of 154.53K.
It is down -7.03% in the last 24 hours and up +3.12% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
See More
Previous Close:
$4.98
Open:
$4.8
24h Volume:
154.53K
Relative Volume:
1.93
Market Cap:
$157.18M
Revenue:
$8.98M
Net Income/Loss:
$-31.39M
P/E Ratio:
-3.4552
EPS:
-1.34
Net Cash Flow:
$-24.83M
1W Performance:
-11.47%
1M Performance:
+3.12%
6M Performance:
-47.09%
1Y Performance:
-45.66%
1-Day Range:
$4.40
$4.99
1-Week Range:
$4.40
$5.6238
52-Week Range:
$3.895
$11.42
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
647-476-1350
Address
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
4.63 | 157.18M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Lake Street | Buy |
| Jul-16-24 | Upgrade | Stifel | Hold → Buy |
| Nov-28-23 | Initiated | Stifel | Hold |
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
View All
Profound Medical Corp Stock (PROF) Latest News
Profound Medical Corp. (NASDAQ:PROF) Q1 2025 Earnings Call Transcript - Insider Monkey
Profound Medical stock rating downgraded at Raymond James By Investing.com - Investing.com Nigeria
Profound Medical stock rating downgraded at Raymond James - Investing.com
Profound Medical (PROF) Downgraded by Raymond James Amid Economic Concerns | PROF Stock News - GuruFocus
Profound Medical Q1 2025 revenue jumps 82% - Medical Buyer
Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo
Earnings call transcript: Profound Medical Q1 2025 sees revenue surge - Investing.com
Profound Medical Q1 2025 Earnings Call Transcript - MarketBeat
Profound Medical Corp. Q1 Loss Increases, Misses Estimates - Nasdaq
Profound Medical Reports Strong Q1 2025 Growth and Highlights TULSA-PRO Advancements - TipRanks
Profound Medical Announces First Quarter 2025 Financial Results - The Manila Times
Profound Medical Corp (TSX:PRN) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus
(PRN) Dynamic Trading Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical Corp expected to post a loss of 29 cents a shareEarnings Preview - TradingView
Learn to Evaluate (PRN) using the Charts (PRN:CA) - news.stocktradersdaily.com
Strong week for Profound Medical (TSE:PRN) shareholders doesn't alleviate pain of five-year loss - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Profound Medical: In Serious Trouble Despite Projected Growth (NASDAQ:PROF) - Seeking Alpha
Profound Medical to Present at 2025 Healthcare Investor Conference - TipRanks
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference - The Manila Times
XTX Topco Ltd Buys New Position in Profound Medical Corp. (NASDAQ:PROF) - Defense World
Is Profound Medical a buy right now? - Cantech Letter
Toronto Stocks Flat as Liberals Clinch Fourth Term Government; Profound Medical Shares Up - marketscreener.com
Profound Medical (PROF) Showcases Promising TULSA Procedure Resu - GuruFocus
Stocks In Play: Profound Medical Corp. - Barchart.com
Profound Medical Corp. - Baystreet.ca
Profound Medical Announces Positive CAPTAIN Trial Results - TipRanks
Profound Medical Brief: Says Provides "Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy" - marketscreener.com
Profound Medical Brief: Detailing Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA - marketscreener.com
Profound Medical Highlights TULSA-PRO at Urology Meeting - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp.PROF - PR Newswire
Bank of Montreal Can Decreases Stake in Profound Medical Corp. (NASDAQ:PROF) - Defense World
(PRN) Investment Report (PRN:CA) - news.stocktradersdaily.com
Lake Street Capital Cuts Profound Medical (NASDAQ:PROF) Price Target to $11.00 - Defense World
(PRN) Trading Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical (PROF) Price Target Cut Ahead of Study Release - GuruFocus
Profound Medical (PROF) Price Target Cut Ahead of Study Release | PROF Stock News - GuruFocus
Profound Medical announces annual meeting details - Investing.com Australia
Profound Medical announces annual meeting details By Investing.com - Investing.com India
(PRN) Investment Performance Report (PRN:CA) - news.stocktradersdaily.com
Bronstein, Gewirtz & Grossman, LLC Encourages Profound Medical Co - NatLawReview.com
(PROF) Investment Report - news.stocktradersdaily.com
(PRN) Investment Analysis (PRN:CA) - news.stocktradersdaily.com
Profound Medical to Announce Q1 2025 Financial Results - TipRanks
Profound Medical to Release First Quarter 2025 Financial Results on May 8Conference Call to Follow - The Manila Times
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow - The Spec
With 56% institutional ownership, Profound Medical Corp. (TSE:PRN) is a favorite amongst the big guns - Yahoo Finance
High Intensity Focused Ultrasound (HIFU) Market to Reach $1.81 Billion by 2034, Growing at a CAGR of 10.4% | Rising Demand for Non-Invasive Therapeutic Solutions Driving Global Market Expansion - GlobeNewswire Inc.
Profound Medical AUA 2025 Investor Event Agenda - Lelezard
(PRN) Strategic Investment Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical AUA 2025 Investor Event Agenda | PROF Stock New - GuruFocus
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):